Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vani Santhosh"'
Autor:
Sneha Dayanand Kamath, Maya Dattatraya Bhat, Vani Santhosh, Gautham Arunachal, A R Prabhuraj, Karthik Kulanthaivelu, Sabha Ahmed, Ajay Asranna, Raghavendra Kenchaiah
Publikováno v:
Annals of Indian Academy of Neurology, Vol 26, Iss 4, Pp 603-606 (2023)
Externí odkaz:
https://doaj.org/article/a1ded5d32b664b8b9eabac7399d48be5
Autor:
A Arivazhagan, Kumaravel Somasundaram, Siva Umapathy, Abhirami Visvanathan, Vani Santhosh, Srividya Kumar
Publikováno v:
Biomedical Spectroscopy, Microscopy, and Imaging.
Autor:
Vani Santhosh, Siva Umapathy, Arimappamagan Arivazhagan, Srividya Kumar, Kumaravel Somasundaram, Abhirami Visvanathan
Publikováno v:
IndraStra Global.
Radiation is the standard therapy used for treating Glioblastoma (GBM), a grade IV brain cancer. Glioma Stem-like Cells (GSCs), an integral part of GBM, enforces resistance to radiation therapy of GBM. Studying the differential biomolecular compositi
Autor:
Vani Santhosh
Publikováno v:
Ramamurthi and Tandon�s Manual of Neurosurgery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b06a785cb8f7499774886d9f2ad90f1
https://doi.org/10.5005/jp/books/12212_40
https://doi.org/10.5005/jp/books/12212_40
Autor:
Vani Santhosh
Publikováno v:
Ramamurthi and Tandon�s Manual of Neurosurgery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f95235e618e56e81b40723b921dca312
https://doi.org/10.5005/jp/books/12212_30
https://doi.org/10.5005/jp/books/12212_30
Autor:
Vani Santhosh
Publikováno v:
Ramamurthi and Tandon�s Manual of Neurosurgery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9aa8433ce701e0436f1e7a4ec9fa5f0c
https://doi.org/10.5005/jp/books/12212_28
https://doi.org/10.5005/jp/books/12212_28
Publikováno v:
Journal of Cancer Research and Therapeutics. 5:44
2-Deoxy-D-glucose (2-DG), an inhibitor of glucose transport and glycolysis, enhances radiation damage selectively in tumor cells by modulating damage response pathways resulting in cell death in vitro and local tumor control. Phase I and II clinical